Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan

# Background Antibody-based serological tests which target households and communities can estimate the true extent of infection in a population. It minimizes the biases of facility-based selective testing and generates scientific data on disease transmission through household asymptomatic cases. Th...

Full description

Bibliographic Details
Main Authors: Muhammad Imran Nisar, Mashal Amin, Nadia Ansari, Farah Khalid, Najeeb Rehman, Aneeta Hotwani, Usma Mehmood, Arslan Memon, Junaid Iqbal, Ali Faisal Saleem, Daniel B. Larremore, Bailey Fosdick, Fyezah Jehan
Format: Article
Language:English
Published: Inishmore Laser Scientific Publishing Ltd 2023-07-01
Series:Journal of Global Health Reports
Online Access:https://doi.org/10.29392/001c.84241
_version_ 1797371638351659008
author Muhammad Imran Nisar
Mashal Amin
Nadia Ansari
Farah Khalid
Najeeb Rehman
Aneeta Hotwani
Usma Mehmood
Arslan Memon
Junaid Iqbal
Ali Faisal Saleem
Daniel B. Larremore
Bailey Fosdick
Fyezah Jehan
author_facet Muhammad Imran Nisar
Mashal Amin
Nadia Ansari
Farah Khalid
Najeeb Rehman
Aneeta Hotwani
Usma Mehmood
Arslan Memon
Junaid Iqbal
Ali Faisal Saleem
Daniel B. Larremore
Bailey Fosdick
Fyezah Jehan
author_sort Muhammad Imran Nisar
collection DOAJ
description # Background Antibody-based serological tests which target households and communities can estimate the true extent of infection in a population. It minimizes the biases of facility-based selective testing and generates scientific data on disease transmission through household asymptomatic cases. The objective of this study was to determine the seroprevalence and trend of SARS-CoV-2 in a densely populated urban community of Karachi. # Methods Three serial cross-sectional surveys were conducted in November 2020, February 2021, and December 2021 in Karachi's District East. Households were selected to provide serum samples for Elecsys® immunoassay for the detection of SARS-CoV-2 antibodies. All household members were eligible to participate regardless of age and infection status. Bayesian regression was used to adjust for assay performance and estimate seroprevalence. # Results We enrolled 1506 participants from 501 households. In November 2020, adjusted seroprevalence was estimated as 24.0% (95% confidence interval, CI=18.0-31.0), compared to 53.9% (95% CI=45.5-63.2) in February. In December 2021, it increased to 84.9% (95% CI=78.5-92.3). The conditional risk of infection was 41% (95% CI=29.9-51.6), 56.7% (95% CI=50.4--62.6) and 77.8% (95% CI=73.0-81.7) in surveys 4, 5, and 6 respectively. Only 18.7% of participants who had reactive antibodies for COVID-19 were symptomatic. # Conclusions An increase in seroprevalence estimates in Karachi's District East was observed over time. Community-based seroprevalence studies help to estimate the true proportion of the population that has been infected and predicts the spread of the disease in similar settings.
first_indexed 2024-03-08T18:22:55Z
format Article
id doaj.art-84712037634b4c41a49cffa66131fc9c
institution Directory Open Access Journal
issn 2399-1623
language English
last_indexed 2024-03-08T18:22:55Z
publishDate 2023-07-01
publisher Inishmore Laser Scientific Publishing Ltd
record_format Article
series Journal of Global Health Reports
spelling doaj.art-84712037634b4c41a49cffa66131fc9c2023-12-30T17:13:13ZengInishmore Laser Scientific Publishing LtdJournal of Global Health Reports2399-16232023-07-017Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, PakistanMuhammad Imran NisarMashal AminNadia AnsariFarah KhalidNajeeb RehmanAneeta HotwaniUsma MehmoodArslan MemonJunaid IqbalAli Faisal SaleemDaniel B. LarremoreBailey FosdickFyezah Jehan# Background Antibody-based serological tests which target households and communities can estimate the true extent of infection in a population. It minimizes the biases of facility-based selective testing and generates scientific data on disease transmission through household asymptomatic cases. The objective of this study was to determine the seroprevalence and trend of SARS-CoV-2 in a densely populated urban community of Karachi. # Methods Three serial cross-sectional surveys were conducted in November 2020, February 2021, and December 2021 in Karachi's District East. Households were selected to provide serum samples for Elecsys® immunoassay for the detection of SARS-CoV-2 antibodies. All household members were eligible to participate regardless of age and infection status. Bayesian regression was used to adjust for assay performance and estimate seroprevalence. # Results We enrolled 1506 participants from 501 households. In November 2020, adjusted seroprevalence was estimated as 24.0% (95% confidence interval, CI=18.0-31.0), compared to 53.9% (95% CI=45.5-63.2) in February. In December 2021, it increased to 84.9% (95% CI=78.5-92.3). The conditional risk of infection was 41% (95% CI=29.9-51.6), 56.7% (95% CI=50.4--62.6) and 77.8% (95% CI=73.0-81.7) in surveys 4, 5, and 6 respectively. Only 18.7% of participants who had reactive antibodies for COVID-19 were symptomatic. # Conclusions An increase in seroprevalence estimates in Karachi's District East was observed over time. Community-based seroprevalence studies help to estimate the true proportion of the population that has been infected and predicts the spread of the disease in similar settings.https://doi.org/10.29392/001c.84241
spellingShingle Muhammad Imran Nisar
Mashal Amin
Nadia Ansari
Farah Khalid
Najeeb Rehman
Aneeta Hotwani
Usma Mehmood
Arslan Memon
Junaid Iqbal
Ali Faisal Saleem
Daniel B. Larremore
Bailey Fosdick
Fyezah Jehan
Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
Journal of Global Health Reports
title Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
title_full Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
title_fullStr Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
title_full_unstemmed Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
title_short Community-based seroprevalence of SARS CoV-2 in an urban district of Karachi, Pakistan
title_sort community based seroprevalence of sars cov 2 in an urban district of karachi pakistan
url https://doi.org/10.29392/001c.84241
work_keys_str_mv AT muhammadimrannisar communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT mashalamin communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT nadiaansari communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT farahkhalid communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT najeebrehman communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT aneetahotwani communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT usmamehmood communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT arslanmemon communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT junaidiqbal communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT alifaisalsaleem communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT danielblarremore communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT baileyfosdick communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan
AT fyezahjehan communitybasedseroprevalenceofsarscov2inanurbandistrictofkarachipakistan